After his colon cancer returned in full force, Marine Corps veteran Joe Worthy decided to help other veterans, advocating for ...

NGS utilization increased over time but left substantial proportions untested across metastatic breast, prostate, pancreatic, ...

These advances, still under investigation, hold the promise of revolutionizing healthcare for future colorectal cancer ...

PDS01ADC is a tumor-targeted IL-12 immunocytokine designed to activate the immune system directly within the tumor ...

In the STELLAR-303 trial, zanzalintinib plus atezolizumab significantly reduced the risk of death by 20% compared with regorafenib in the ITT population. The Food and Drug Administration (FDA) has ...

Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapeutics for oncology and rare diseases, today announced ...

Detailed price information for Pds Biotechnology Corp (PDSB-Q) from The Globe and Mail including charting and trades.

NEXT-GENERATION sequencing use rose in advanced cancer, but access remained uneven across socioeconomic, racial, and ...